Skip to main content
SpringerLink
Log in

Skin Manifestations of Raynaud’s Phenomenon

  • Chapter
  • First Online:
Skin Manifestations in Rheumatic Disease

  • 2125 Accesses

Abstract

Raynaud’s phenomenon presents clinically as cold mottled skin and most commonly involves the extremities. It results from vasoconstriction of the superficial thermoregulatory vessels as an exaggerated response to cold temperatures and/or to stress. It can occur primarily, without an associated autoimmune disease, or can relate to underlying rheumatic diseases such as scleroderma or mixed connective tissue disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gelber AC, Wigley FM, Stallings RY, et al. Symptoms of Raynaud’s phenomenon in an inner-city African-American community: prevalence and self-reported cardiovascular comorbidity. J Clin Epidemiol. 1999;52:441–6.

    Article  PubMed  CAS  Google Scholar 

  2. Block JA, Sequeira W. Raynaud’s phenomenon. Lancet. 2001;357:2042–8.

    Article  PubMed  CAS  Google Scholar 

  3. Maricq HR, Carpentier PH, Weinrich MC, et al. Geographic variation in the prevalence of Raynaud’s phenomenon: Charleston, SC, USA, vs Tarentaise, Savoie, France. J Rheumatol. 1993;20:70–6.

    PubMed  CAS  Google Scholar 

  4. Sharp GC, Irvin WS, May CM, et al. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases. N Engl J Med. 1976;295:1149–4.

    Article  PubMed  CAS  Google Scholar 

  5. Tuffanelli DL, Winkelmann RK. Systemic scleroderma, a clinical study of 727 cases. Arch Dermatol. 1961;84:359–1.

    Article  PubMed  CAS  Google Scholar 

  6. Parker MD. Ribonucleoprotein antibodies: frequency and clinical significance in systemic lupus erythematosus, scleroderma, and mixed connective tissue disease. J Lab Clin Med. 1973;82:769–5.

    PubMed  CAS  Google Scholar 

  7. Cohen ML, Dawkins B, Dawkins RL, et al. Clinical significance of antibodies to ribonucleoprotein. Ann Rheum Dis. 1979;38:74–8.

    Article  PubMed  CAS  Google Scholar 

  8. De Angelis R, Cerioni A, Del Medico P, et al. Raynaud’s phenomenon in undifferentiated connective tissue disease (UCTD). Clin Rheumatol. 2005;24:145–51.

    Article  PubMed  Google Scholar 

  9. Mosca M, Neri R, Bencivelli W, et al. Undifferentiated connective tissue disease: analysis of 83 patients with a minimum followup of 5 years. J Rheumatol. 2002;29:2345–9.

    PubMed  Google Scholar 

  10. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore). 1971;50:85–95.

    CAS  Google Scholar 

  11. Hochberg MC, Boyd RE, Ahearn JM, et al. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore). 1985;64:285–95.

    CAS  Google Scholar 

  12. Saraux A, Allain J, Guedes C, et al. Raynaud’s phenomenon in rheumatoid arthritis. Br J Rheumatol. 1996;35:752–4.

    Article  PubMed  CAS  Google Scholar 

Suggested Readings

  • Boin F, Wigley FM. Understanding, assessing and treating Raynaud’s phenomenon. Curr Opin Rheumatol. 2005;17:752–60.

    PubMed  CAS  Google Scholar 

  • Flavahan NA. Regulation of vascular activity in scleroderma: new insights into Raynaud’s phenomenon. Rheum Dis Clin North Am. 2008;34(1):81–7; vii.

    Google Scholar 

  • Generini S, Seibold JR, Matucci-Cerinic M. Estrogens and neuropeptides in Raynaud’s phenomenon. Rheum Dis Clin North Am. 2005; 31:177–86, x–xi.

    Google Scholar 

  • Henness S, Wigley FM. Current drug therapy for scleroderma and secondary Raynaud’s phenomenon. Curr Opin Rheumatol. 2007;19(6):611–8.

    Article  PubMed  CAS  Google Scholar 

  • Herrick AL. Pathogenesis of Raynaud’s phenomenon. Rheumatology. 2005;44:587–96.

    Article  PubMed  CAS  Google Scholar 

  • Herrick AL. Therapy: a local approach to Raynaud phenomenon. Nat Rev Rheumatol. 2009;5:246–7.

    Article  PubMed  CAS  Google Scholar 

  • Malenfant D, Catton M, Pope JE. The efficacy of complementary and alternative medicine in the treatment of Raynaud’s phenomenon: a literature review and meta-analysis. Rheumatology (Oxford). 2009;48:791–5.

    Article  Google Scholar 

  • Steen V, Denton CP, Pope JE, Matucci-Cerinic M. Digital ulcers: overt vascular disease in scleroderma. Rheumatology (Oxford). 2009;48 Suppl 3:iii19–24.

    Article  Google Scholar 

  • Thompson AE, Pope JE. Calcium channel blockers for primary Raynaud’s phenomenon: a meta-analysis. Rheumatology (Oxford). 2005;44:145–50.

    Article  CAS  Google Scholar 

  • Wigley FM. Raynaud’s phenomenon. N Eng J Med. 2002;347:1001–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Johns Hopkins Scleroderma Center, 5200 Eastern Avenue, Mason F. Lord Building, Center Tower, Suite 4100, Baltimore, MD, 21224, USA

    Noëlle S. Sherber M.D.

  2. Division of Rheumatology, Johns Hopkins University School of Medicine, 5200 Eastern Avenue, Mason F. Lord Building, Center Tower, Suite 4100, Baltimore, MD, 21224, USA

    Fredrick M. Wigley M.D.

Authors
  1. Noëlle S. Sherber M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fredrick M. Wigley M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Noëlle S. Sherber M.D. .

Editor information

Editors and Affiliations

  1. Division of Rheumatology, University of Florence Department of Biomedicine, Florence, Italy

    Marco Matucci-Cerinic

  2. Division of Rheumatology, UCLA Medical Center Department of Medicine, Los Angeles, California, USA

    Daniel Furst

  3. Department of Dermatology, Stanford University School of Medicine, Redwood City, California, USA

    David Fiorentino

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Sherber, N.S., Wigley, F.M. (2014). Skin Manifestations of Raynaud’s Phenomenon. In: Matucci-Cerinic, M., Furst, D., Fiorentino, D. (eds) Skin Manifestations in Rheumatic Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7849-2_23

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-7849-2_23

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-7848-5

  • Online ISBN: 978-1-4614-7849-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation